Joseph P. Newhouse

Joseph P. Newhouse

Auto-generated profile, based on publicly available information

Joseph P. Newhouse

Center for Global Health and Mongan Institute, Massachusetts General Hospital Boston Massachusetts USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1998 in Annual Review of Public Health
Verified
Journal Article
Closed access
JNJoseph P. Newhouse
Joseph P. Newhouse
MMMark McClellan
Mark McClellan
▪ Abstract We describe an econometric technique, instrumental variables, that can be useful in estimating the effectiveness of clinical treatments in situations when a controlled trial has not or cannot be done. This technique relies upon the existence of one or more variables that induce substantial variation in the treatment variable but have no direct effect on the outcome variable of interest. We illustrate the use of the technique with an application to aggressive treatment of acute myocardial infarction in the elderly.

5 January 2006 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
EPEric G Poon
Eric G Poon
AJAshish K Jha
Ashish K Jha
MCMelissa Christino
Melissa Christino
MHMelissa M Honour
Melissa M Honour
RFRushika Fernandopulle
Rushika Fernandopulle
RKRainu Kaushal
Rainu Kaushal
Background: Comprehensive knowledge about the level of healthcare information technology (HIT) adoption in the United States remains limited. We therefore performed a baseline assessment to address this knowledge gap. Methods: We segmented HIT into eight major stakeholder groups and identified major functionalities that should ideally exist for each, focusing on applications most likely to improve patient safety, quality of care and organizational efficiency. We then conducted a multi-site qualitative study in Boston and Denver by interviewing key informants from each stakeholder group. Interview transcripts were analyzed to assess the level of adoption and to document the major barriers to further adoption. Findings for Boston and Denver were then presented to an expert panel, which was then asked to estimate the national level of adoption using the modified Delphi approach. We measured adoption level in Boston and Denver was graded on Rogers' technology adoption curve by co-investigators. National estimates from our expert panel were expressed as percentages. Results: Adoption of functionalities with financial benefits far exceeds adoption of those with safety and quality benefits. Despite growing interest to adopt HIT to improve safety and quality, adoption remains limited, especially in the area of ambulatory electronic health records and physician-patient communication. Organizations, particularly physicians' practices, face enormous financial challenges in adopting HIT, and concerns remain about its impact on productivity. Conclusion: Adoption of HIT is limited and will likely remain slow unless significant financial resources are made available. Policy changes, such as financial incentivesto clinicians to use HIT or pay-for-performance reimbursement, may help health care providers defray upfront investment costs and initial productivity loss.

25 September 2013 in JAMA
Verified
Journal Article
Closed access
PDF file
JNJoseph P. Newhouse
Joseph P. Newhouse
AGAlan M. Garber
Alan M. Garber
Geographic variation in per-beneficiary Medicare spending that cannot be explained by wages and the prices of other inputs to health care or by demographic and

1 November 2004 in Health Affairs
Verified
Journal Article
Closed access
JNJoseph P. Newhouse
Joseph P. Newhouse
Today’s consumer-directed health plans, with their high deductibles, bear a strong resemblance to the high-deductible plan of the RAND Health Insurance Experiment (HIE), although they come into a post–managed care world. The high deductibles and the tools of managed care should complement each other, the former directed primarily at the initiation of care for an episode of illness and the latter at the costliness of episodes, especially ongoing chronic disease episodes. Although the RAND experiment established the effects of varying prices to patients, future experiments with how physicians respond to the various tools of managed care may be useful.

1 December 2012 in Health Affairs
Verified
Journal Article
Closed access
JNJoseph P. Newhouse
Joseph P. Newhouse
MPMary Price
Mary Price
JHJie Huang
Jie Huang
JMJ. Michael McWilliams
J. Michael McWilliams
JHJohn Hsu
John Hsu
Within Medicare, the Medicare Advantage program has historically attracted better risks—healthier, lower-cost patients—than has traditional Medicare. The disproportionate enrollment of lower-cost patients and avoidance of higher-cost ones during the 1990s—known as favorable selection—resulted in Medicare’s spending more per beneficiary who enrolled in Medicare Advantage than if the enrollee had remained in traditional Medicare. We looked at two measures that can indicate whether favorable selection is taking place—predicted spending on beneficiaries and mortality—and studied whether policies that Medicare implemented in the past decade succeeded in reducing favorable selection in Medicare Advantage. We found that these policies—an improved risk adjustment formula and a prohibition on monthly disenrollment by beneficiaries—largely succeeded. Differences in predicted spending between those switching from traditional Medicare to Medicare Advantage relative to those who remained in traditional Medicare marked...

3 June 2014 in The Milbank Quarterly
Verified
Journal Article
Closed access
PDF file
JNJoseph P. Newhouse
Joseph P. Newhouse
TMTHOMAS G. McGUIRE
THOMAS G. McGUIRE